1Tsai SL, Sheen IS, Chien RN, et al. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications[J]. J Biomed Sci,2003,10(1):120-135.
2Jecker P, Mann WJ, McWilliam AS, et al.Dendritic cell influx differs between the subglottic and glottic mucosae during acute laryngotracheitis induced by a broad spectrum of stimuli[J]. Ann Otol Rhinol Laryngol,2002,111(7 Pt 1):567-572.
3Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection[J]. J Gastroenterol Hepatol, 2000,15(4):431-436.
4Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells [J]. J Virol,1995,69(6):3893-3896.
5Fan XG, Liu WE, Li CZ, et al.Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection[J]. Mediators Inflamm,1998,7(4):295-297.
6Sanders RW, de Jong EC, Baldwin CE, et al. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells[J]. J Virol,2002,76(15):7812-7821.
7Sarobe P, Lasarte JJ, Casares N, et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins[J]. J Virol,2002,76(10):5062-5070.
9Santin AD, Bellone S, Gokden M, et al.Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer[J]. N Engl J Med,2002,346(22):1752-1753.
10Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection[J]. Blood,2001,97(10):3171-3176.
